End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.75 CNY | -1.00% | +8.70% | -31.85% |
Apr. 30 | Pharmaron Beijing's Profit Rises 17% in 2023 | MT |
Apr. 29 | Nomura Adjusts Pharmaron’s Price Target to 31.41 Yuan From 36.68 Yuan, Keeps at Buy | MT |
Sales 2024 * | 12.64B 1.75B | Sales 2025 * | 15.26B 2.11B | Capitalization | 32.06B 4.43B |
---|---|---|---|---|---|
Net income 2024 * | 1.6B 222M | Net income 2025 * | 2.18B 301M | EV / Sales 2024 * | 2.78 x |
Net Debt 2024 * | 3.13B 433M | Net Debt 2025 * | 2.34B 324M | EV / Sales 2025 * | 2.25 x |
P/E ratio 2024 * |
21.3
x | P/E ratio 2025 * |
16.6
x | Employees | - |
Yield 2024 * |
1.18% | Yield 2025 * |
1.46% | Free-Float | 47.74% |
1 day | -1.00% | ||
1 week | +8.70% | ||
Current month | -3.04% | ||
1 month | -3.04% | ||
3 months | -10.88% | ||
6 months | -32.94% | ||
Current year | -31.85% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Qiang Lou
FOU | Founder | 55 | 04-06-30 |
Bei Zheng
FOU | Founder | 57 | 04-06-30 |
Bo Liang Lou
CEO | Chief Executive Officer | 60 | 04-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kwan Hung Tsang
BRD | Director/Board Member | 60 | 19-08-14 |
Jia Qing Li
BRD | Director/Board Member | 51 | 16-10-26 |
Bo Liang Lou
CEO | Chief Executive Officer | 60 | 04-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.17% | 2 M€ | -15.79% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 19.75 | -1.00% | 18,590,330 |
24-04-29 | 19.95 | +4.12% | 35,745,700 |
24-04-26 | 19.16 | +5.04% | 35,373,060 |
24-04-25 | 18.24 | +0.39% | 20,412,080 |
24-04-24 | 18.17 | -1.57% | 18,266,280 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.85% | 4.48B | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- 300759 Stock